retatrutide phase 2 results 2024 2025 press release 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide produces up to 30.3%

Call today.

Not intended for pregnant or nursing mothers or children under the age of 18. Individuals taking blood thinners, any other medications, or have any known medical conditions should consult a physician before using any herbal supplements

Introducing the GLP-1 Insurance Coverage Checker a free tool that empowers anyone to check if their insurance covers GLP-1s medications and understand their potential out of pocket costs at the beginning of their journey

What the 503B proposal means for patients, and how to plan a safe transition.

Novo Nordisk, the manufacturer of Ozempic, announced a plan to reduce its global workforce by approximately 9,000 positions today.

Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an